Covaxin, jointly developed by Bharat Biotech and the state-funded Indian Council of Medical Research, was granted an import licence by Brazilian health regulator Anvisa in June this year. Earlier this month, the Brazilian parliamentary commission of inquiry started probing the transaction between Indian firm and India-Brazil Chamber of Commerce.